Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics
Cancer Immunology, Immunotherapy · 03.11.2025 · 74 (12)
DOI: 10.1007/s00262-025-04210-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 03.11.2025. Verfasst von Jungirl Seok und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic …. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Tumor Microenvironment, Transcriptome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Research Foundation of Korea Grant funded by the Korean Government, The Ministry of Education of the Republic of Korea and the National Research Foundation of Korea, National Cancer Center Grants, Republic of Korea.
Abstract (Originalsprache)
Background
Thyroid cancer is the most common endocrine malignancy, with an increasing incidence, particularly driven by differentiated thyroid cancers (DTC), including papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). Although DTC generally have excellent prognosis, dedifferentiated forms such as poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) exhibit aggressive progression and poor outcomes. Understanding the tumor microenvironment (TME) is crucial for developing novel therapeutic strategies.
Methods
We performed spatial transcriptomics (ST) on formalin-fixed paraffin-embedded (FFPE) tumor tissues from 12 patients with PTC, FTC, PDTC, or ATC using the Visium CytAssist platform. Cell type composition was inferred using the CellDART algorithm, and pathway activity was assessed via PROGENy and REACTOME analyses. Immunohistochemical (IHC) assays were conducted to validate key TME components.
Results
ST analysis revealed significant shifts in cell composition associated with thyroid cancer dedifferentiation. Specifically, there was an increase in myeloid cells and cancer-associated fibroblasts (CAFs), accompanied by a reduction in natural killer (NK) cells and endothelial cells. Intratumoral heterogeneity in the Thyroid Differentiation Score (TDS) showed a strong spatial correlation with myeloid cell density, and among myeloid subtypes, the MDSC score was negatively correlated with TDS. Pathway activity analysis further identified upregulation of the JAK-STAT and VEGF signaling pathways in dedifferentiated tumors, both of which were closely associated with increased myeloid cell infiltration. IHC validation confirmed the differential expression patterns of representative immune and stromal markers across subtypes.
Conclusions
These findings suggest that dedifferentiation in thyroid cancer is associated with an immunosuppressive TME that promotes tumor progression. Therapeutic strategies targeting JAK-STAT and VEGF pathways, or enhancing NK cell activity, may hold promises for aggressive thyroid cancers. Further studies with larger cohorts are necessary to validate these findings and develop targeted therapies for aggressive thyroid cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic of Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Portrai, Inc., Seoul, Republic of Korea.
- Department of Internal Medicine, National Cancer Center, Goyang, Republic of Korea.
- Department of Pathology, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic of Korea. 11740@ncc.re.kr.
Förderung
- The National Research Foundation of Korea Grant funded by the Korean Government
- The Ministry of Education of the Republic of Korea and the National Research Foundation of Korea
- National Cancer Center Grants, Republic of Korea
Zitieren
APA
Seok, J., Choi, H., Lee, E. K., Ryu, C. H., Lee, D., Ryu, J., Park, S. Y., & Jung, Y. S. (2025). Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics. Cancer Immunology, Immunotherapy, 74(12). https://doi.org/10.1007/s00262-025-04210-0
Vancouver
Seok J, Choi H, Lee EK, Ryu CH, Lee D, Ryu J, et al. Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics. Cancer Immunology, Immunotherapy. 2025;74(12). doi:10.1007/s00262-025-04210-0
BibTeX
@article{Seok2025,
author = {Seok, Jungirl and Choi, Hongyoon and Lee, Eun Kyung and Ryu, Chang Hwan and Lee, Dongjoo and Ryu, Junsun and Park, Seog Yun and Jung, Yuh-Seog},
title = {Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
volume = {74},
number = {12},
doi = {10.1007/s00262-025-04210-0}
}
EUVIMED